Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex inches closer to acute pain market with FDA application acceptance
Fierce Biotech
Thu, 04/18/24 - 11:10 am
Vertex Pharmaceuticals
VX-548
acute pain
painkillers
FDA
non-opioid pain treatments
What about the company Vertex didn’t buy?
Stat
Fri, 04/12/24 - 11:05 am
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
Vera Therapeutics
IgA nephropathy
Vertex to buy kidney disease drugmaker Alpine for $4.9B
BioPharma Dive
Wed, 04/10/24 - 06:05 pm
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
IgA nephropathy
High-flying Vertex hikes CEO Reshma Kewalramani's pay by 30% to $20.6M
Fierce Pharma
Mon, 04/8/24 - 05:52 pm
Vertex Pharmaceuticals
Reshma Kewalramani
Pharma CEOs
executive compensation
Vertex moves kidney disease drug into late-stage testing
BioPharma Dive
Mon, 04/1/24 - 11:21 pm
Vertex Pharmaceuticals
kidney disease
inaxaplin
Vertex Fails to Convince UK Watchdog of CRISPR Therapy Casgevy’s Value
BioSpace
Thu, 03/14/24 - 06:19 pm
Vertex Pharmaceuticals
UK
sickle cell disease
CRISPR
Casgevy
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market?
Motley Fool
Sun, 02/18/24 - 08:27 pm
Vertex Pharmaceuticals
painkillers
VX-548
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Vertex's triple combo cystic-fibrosis drug meets main late-stage study goals
Reuters
Mon, 02/5/24 - 10:57 pm
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
Vanza Triple
Non-opioid drug from Vertex cuts pain in major trial tests
BioPharma Dive
Tue, 01/30/24 - 10:18 am
Vertex Pharmaceuticals
non-opioid pain treatments
clinical trials
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
Motley Fool
Thu, 01/25/24 - 11:01 am
Sarepta Therapeutics
Vertex Pharmaceuticals
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
Sickle Cell Gene Therapies Seen as Cost Effective Below $2M Threshold: Study
BioSpace
Tue, 01/23/24 - 11:18 am
gene therapy
sickle cell disease
drug pricing
Vertex Pharmaceuticals
Bluebird Bio
FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia
BioPharma Dive
Wed, 01/17/24 - 09:34 am
Vertex Pharmaceuticals
CRISPR Therapeutics
Casgevy
beta thalassemia
FDA
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
Two Patient Deaths Force Vertex to Pause Diabetes Trial
BioSpace
Mon, 01/8/24 - 11:31 am
Vertex Pharmaceuticals
type 1 diabetes
VX-880
patient deaths
clinical trials
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
Editas and Vertex Ink Deal for Cas9 License for $50M Upfront
BioSpace
Wed, 12/13/23 - 10:07 pm
Editas Medicine
Vertex Pharmaceuticals
Cas9
Casgevy
Vertex Non-Opioid Pain Candidate Shows Promising Phase II Results
BioSpace
Wed, 12/13/23 - 09:43 am
Vertex Pharmaceuticals
clinical trials
VX-548
diabetic peripheral neuropathy
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »